TrialHaematologica2017

Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14.

Mark Hertzberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.